Barbara Marie O'Brien, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Diagnosis | 10 | 2019 | 1236 | 1.650 |
Why?
|
| Fetofetal Transfusion | 10 | 2015 | 104 | 1.080 |
Why?
|
| Genetic Counseling | 3 | 2018 | 600 | 0.980 |
Why?
|
| Fetal Diseases | 5 | 2014 | 903 | 0.930 |
Why?
|
| Aneuploidy | 6 | 2023 | 530 | 0.900 |
Why?
|
| DNA | 7 | 2017 | 7301 | 0.670 |
Why?
|
| Fetoscopy | 7 | 2014 | 121 | 0.660 |
Why?
|
| Rh Isoimmunization | 1 | 2018 | 21 | 0.640 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2018 | 587 | 0.630 |
Why?
|
| Genetics | 1 | 2018 | 112 | 0.610 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2017 | 56 | 0.570 |
Why?
|
| Laser Therapy | 8 | 2014 | 1072 | 0.570 |
Why?
|
| Genetic Testing | 7 | 2018 | 3444 | 0.550 |
Why?
|
| Certification | 1 | 2018 | 424 | 0.500 |
Why?
|
| Dendrites | 1 | 2017 | 485 | 0.500 |
Why?
|
| Pamphlets | 2 | 2014 | 75 | 0.490 |
Why?
|
| Nociceptors | 1 | 2017 | 432 | 0.470 |
Why?
|
| Pregnancy | 33 | 2023 | 29144 | 0.460 |
Why?
|
| HLA Antigens | 1 | 2018 | 1381 | 0.420 |
Why?
|
| Emotions | 1 | 2023 | 2661 | 0.400 |
Why?
|
| Erythroblastosis, Fetal | 1 | 2011 | 60 | 0.380 |
Why?
|
| Communication | 2 | 2023 | 3749 | 0.380 |
Why?
|
| Foodborne Diseases | 1 | 2010 | 39 | 0.370 |
Why?
|
| Quadruplets | 1 | 2010 | 9 | 0.370 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 1179 | 0.360 |
Why?
|
| Blood Component Removal | 1 | 2011 | 125 | 0.360 |
Why?
|
| Transplantation | 1 | 2010 | 217 | 0.330 |
Why?
|
| ABO Blood-Group System | 1 | 2011 | 367 | 0.320 |
Why?
|
| Education, Nursing, Baccalaureate | 1 | 2008 | 22 | 0.320 |
Why?
|
| Twins | 1 | 2009 | 339 | 0.300 |
Why?
|
| Placenta | 6 | 2019 | 1698 | 0.300 |
Why?
|
| Selection Bias | 1 | 2008 | 371 | 0.270 |
Why?
|
| Trisomy | 4 | 2017 | 266 | 0.270 |
Why?
|
| Hydrops Fetalis | 1 | 2023 | 107 | 0.230 |
Why?
|
| Clinical Competence | 1 | 2018 | 4687 | 0.220 |
Why?
|
| Postpartum Hemorrhage | 1 | 2006 | 258 | 0.210 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2017 | 732 | 0.210 |
Why?
|
| Erythrocytes | 1 | 2011 | 2455 | 0.200 |
Why?
|
| Fathers | 1 | 2023 | 358 | 0.190 |
Why?
|
| Chromosome Disorders | 3 | 2014 | 514 | 0.190 |
Why?
|
| Diseases in Twins | 2 | 2015 | 449 | 0.180 |
Why?
|
| Fetus | 6 | 2019 | 1880 | 0.180 |
Why?
|
| Informed Consent | 2 | 2017 | 995 | 0.170 |
Why?
|
| Pregnancy Outcome | 6 | 2019 | 2795 | 0.170 |
Why?
|
| Ultrasonography, Prenatal | 5 | 2015 | 1695 | 0.170 |
Why?
|
| Female | 42 | 2023 | 380194 | 0.160 |
Why?
|
| Oxytocics | 2 | 2011 | 68 | 0.160 |
Why?
|
| Antigens, Human Platelet | 1 | 2018 | 43 | 0.160 |
Why?
|
| Health Promotion | 1 | 2010 | 2205 | 0.160 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2018 | 65 | 0.160 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 2716 | 0.150 |
Why?
|
| Relaxin | 1 | 2017 | 37 | 0.150 |
Why?
|
| Pregnancy Complications | 4 | 2014 | 2861 | 0.150 |
Why?
|
| Hong Kong | 1 | 2017 | 148 | 0.150 |
Why?
|
| Peripartum Period | 1 | 2018 | 133 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2018 | 3923 | 0.140 |
Why?
|
| Placenta Diseases | 1 | 2019 | 199 | 0.140 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2017 | 186 | 0.140 |
Why?
|
| Karyotyping | 4 | 2014 | 1243 | 0.140 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2014 | 140 | 0.140 |
Why?
|
| Premature Birth | 2 | 2023 | 1721 | 0.140 |
Why?
|
| Fetal Death | 3 | 2019 | 448 | 0.140 |
Why?
|
| Early Detection of Cancer | 3 | 2015 | 3086 | 0.130 |
Why?
|
| Counseling | 1 | 2023 | 1523 | 0.130 |
Why?
|
| Zinc Fingers | 1 | 2017 | 585 | 0.130 |
Why?
|
| Embryo Transfer | 1 | 2019 | 510 | 0.130 |
Why?
|
| Platelet Transfusion | 1 | 2018 | 314 | 0.130 |
Why?
|
| Cri-du-Chat Syndrome | 1 | 2014 | 13 | 0.120 |
Why?
|
| Oxytocin | 2 | 2011 | 394 | 0.120 |
Why?
|
| Humans | 49 | 2023 | 744343 | 0.120 |
Why?
|
| Mosaicism | 2 | 2014 | 441 | 0.120 |
Why?
|
| Prader-Willi Syndrome | 1 | 2014 | 79 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2014 | 351 | 0.110 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2019 | 489 | 0.110 |
Why?
|
| Sensory Receptor Cells | 1 | 2017 | 492 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2014 | 354 | 0.110 |
Why?
|
| Pregnant Women | 1 | 2017 | 568 | 0.110 |
Why?
|
| Twins, Monozygotic | 1 | 2014 | 458 | 0.100 |
Why?
|
| Angelman Syndrome | 1 | 2014 | 136 | 0.100 |
Why?
|
| Quality Control | 1 | 2015 | 841 | 0.100 |
Why?
|
| Ethics, Medical | 1 | 2017 | 792 | 0.100 |
Why?
|
| Sigmoidoscopy | 1 | 2012 | 156 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2014 | 658 | 0.100 |
Why?
|
| Craniopharyngioma | 1 | 2014 | 281 | 0.100 |
Why?
|
| Delivery, Obstetric | 2 | 2011 | 906 | 0.100 |
Why?
|
| Prenatal Care | 2 | 2017 | 1092 | 0.100 |
Why?
|
| Mass Screening | 4 | 2017 | 5255 | 0.100 |
Why?
|
| Choice Behavior | 1 | 2017 | 803 | 0.100 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2017 | 852 | 0.100 |
Why?
|
| Midwifery | 1 | 2012 | 132 | 0.100 |
Why?
|
| United States Department of Agriculture | 1 | 2010 | 48 | 0.090 |
Why?
|
| Hemoglobinometry | 1 | 2010 | 35 | 0.090 |
Why?
|
| Food Handling | 1 | 2010 | 145 | 0.090 |
Why?
|
| Pitch Perception | 1 | 2011 | 114 | 0.090 |
Why?
|
| Ischemia | 1 | 2019 | 1907 | 0.090 |
Why?
|
| Misoprostol | 1 | 2011 | 95 | 0.090 |
Why?
|
| Stillbirth | 1 | 2012 | 346 | 0.090 |
Why?
|
| Geniculate Bodies | 1 | 2011 | 163 | 0.090 |
Why?
|
| Focus Groups | 2 | 2014 | 1321 | 0.090 |
Why?
|
| Spectrophotometry | 1 | 2010 | 313 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2014 | 1401 | 0.090 |
Why?
|
| Down Syndrome | 2 | 2017 | 880 | 0.080 |
Why?
|
| Digital Rectal Examination | 1 | 2009 | 42 | 0.080 |
Why?
|
| Tachycardia, Ectopic Atrial | 1 | 2009 | 66 | 0.080 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2013 | 482 | 0.080 |
Why?
|
| Auditory Pathways | 1 | 2011 | 233 | 0.080 |
Why?
|
| Anxiety | 1 | 2023 | 4297 | 0.080 |
Why?
|
| Chromosome Aberrations | 2 | 2012 | 1813 | 0.080 |
Why?
|
| Blood Donors | 1 | 2011 | 355 | 0.080 |
Why?
|
| Congenital Abnormalities | 2 | 2015 | 707 | 0.080 |
Why?
|
| Caenorhabditis elegans | 1 | 2017 | 1419 | 0.080 |
Why?
|
| Pre-Eclampsia | 1 | 2017 | 1200 | 0.080 |
Why?
|
| Laser Coagulation | 1 | 2010 | 326 | 0.080 |
Why?
|
| Nursing Research | 1 | 2008 | 77 | 0.080 |
Why?
|
| Audiovisual Aids | 1 | 2008 | 92 | 0.070 |
Why?
|
| Adult | 16 | 2019 | 214055 | 0.070 |
Why?
|
| Auditory Cortex | 1 | 2011 | 346 | 0.070 |
Why?
|
| Maternal Health Services | 1 | 2012 | 455 | 0.070 |
Why?
|
| Ergonovine | 1 | 2006 | 15 | 0.070 |
Why?
|
| Labor Stage, Third | 1 | 2006 | 5 | 0.070 |
Why?
|
| Anesthesia, General | 1 | 2014 | 1171 | 0.070 |
Why?
|
| Amnion | 1 | 2008 | 209 | 0.070 |
Why?
|
| Gynecology | 1 | 2012 | 513 | 0.070 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 242 | 0.070 |
Why?
|
| Erythropoietin | 1 | 2011 | 726 | 0.070 |
Why?
|
| Interprofessional Relations | 1 | 2012 | 1011 | 0.070 |
Why?
|
| Colorectal Neoplasms | 3 | 2015 | 6773 | 0.070 |
Why?
|
| Twinning, Monozygotic | 2 | 2015 | 17 | 0.070 |
Why?
|
| Obstetrics | 1 | 2012 | 658 | 0.060 |
Why?
|
| Prostaglandins | 1 | 2006 | 405 | 0.060 |
Why?
|
| Chorion | 2 | 2015 | 117 | 0.060 |
Why?
|
| Amniotic Fluid | 1 | 2007 | 370 | 0.060 |
Why?
|
| Infant, Newborn | 6 | 2019 | 25625 | 0.060 |
Why?
|
| Problem-Based Learning | 1 | 2008 | 361 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 2278 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 2212 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2015 | 2616 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3920 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2010 | 2539 | 0.060 |
Why?
|
| Abnormalities, Multiple | 2 | 2009 | 1416 | 0.050 |
Why?
|
| Antibodies | 1 | 2011 | 2460 | 0.050 |
Why?
|
| Prostatic Neoplasms | 3 | 2015 | 11124 | 0.050 |
Why?
|
| Ovarian Neoplasms | 2 | 2015 | 4838 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2017 | 7880 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 9648 | 0.050 |
Why?
|
| Cervix Uteri | 1 | 2023 | 590 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 2 | 2015 | 1677 | 0.040 |
Why?
|
| Endoscopy | 1 | 2009 | 1785 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2014 | 1850 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 12072 | 0.040 |
Why?
|
| Prostate-Specific Antigen | 1 | 2009 | 2494 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2011 | 4560 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14722 | 0.040 |
Why?
|
| Young Adult | 4 | 2018 | 56430 | 0.040 |
Why?
|
| Freezing | 1 | 2019 | 303 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2017 | 12208 | 0.040 |
Why?
|
| Inhibins | 1 | 2017 | 211 | 0.040 |
Why?
|
| Microsurgery | 2 | 1980 | 796 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2005 | 1620 | 0.040 |
Why?
|
| Cell-Free System | 1 | 2017 | 344 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 8037 | 0.030 |
Why?
|
| Pregnancy Rate | 1 | 2019 | 643 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 3610 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 6489 | 0.030 |
Why?
|
| Blastocyst | 1 | 2019 | 424 | 0.030 |
Why?
|
| United States | 6 | 2015 | 69872 | 0.030 |
Why?
|
| Germany | 1 | 2017 | 862 | 0.030 |
Why?
|
| Knowledge | 1 | 2017 | 181 | 0.030 |
Why?
|
| Live Birth | 1 | 2019 | 512 | 0.030 |
Why?
|
| Male | 16 | 2023 | 350118 | 0.030 |
Why?
|
| Suture Techniques | 1 | 1979 | 798 | 0.030 |
Why?
|
| Fetal Therapies | 1 | 2015 | 100 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2019 | 670 | 0.030 |
Why?
|
| Risk Factors | 4 | 2019 | 72290 | 0.030 |
Why?
|
| Polycythemia | 1 | 2015 | 126 | 0.030 |
Why?
|
| Middle Cerebral Artery | 1 | 2015 | 264 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2015 | 288 | 0.030 |
Why?
|
| Fetal Heart | 1 | 2015 | 276 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 13102 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2014 | 299 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 8863 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 458 | 0.030 |
Why?
|
| Sigmoidoscopes | 1 | 2012 | 5 | 0.030 |
Why?
|
| Physician-Nurse Relations | 1 | 2012 | 20 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 2012 | 15295 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 496 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 15076 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 3 | 1980 | 1475 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2015 | 9959 | 0.030 |
Why?
|
| Infertility | 1 | 2019 | 655 | 0.030 |
Why?
|
| Organizational Innovation | 1 | 2015 | 559 | 0.020 |
Why?
|
| Neurons | 1 | 2011 | 9338 | 0.020 |
Why?
|
| Thumb | 3 | 1984 | 227 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2014 | 547 | 0.020 |
Why?
|
| Replantation | 2 | 1984 | 148 | 0.020 |
Why?
|
| Chromosomes, Human, 16-18 | 1 | 1970 | 32 | 0.020 |
Why?
|
| Fetal Growth Retardation | 1 | 2015 | 570 | 0.020 |
Why?
|
| Equipment Contamination | 1 | 2012 | 185 | 0.020 |
Why?
|
| Retrospective Studies | 6 | 2019 | 77449 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 457 | 0.020 |
Why?
|
| Cutis Laxa | 1 | 1970 | 29 | 0.020 |
Why?
|
| Autopsy | 1 | 2014 | 1020 | 0.020 |
Why?
|
| Patient Selection | 2 | 2015 | 4215 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2014 | 593 | 0.020 |
Why?
|
| Incidence | 3 | 2014 | 20947 | 0.020 |
Why?
|
| Models, Educational | 1 | 2012 | 377 | 0.020 |
Why?
|
| Polyhydramnios | 1 | 2009 | 41 | 0.020 |
Why?
|
| Gestational Age | 2 | 2009 | 3493 | 0.020 |
Why?
|
| Thoracoscopy | 1 | 2010 | 178 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2012 | 574 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2014 | 722 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 813 | 0.020 |
Why?
|
| Animals | 3 | 2017 | 168757 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2012 | 1526 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2011 | 1308 | 0.020 |
Why?
|
| Monosomy | 1 | 2007 | 54 | 0.020 |
Why?
|
| Minority Groups | 1 | 2015 | 1223 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2017 | 21746 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15540 | 0.020 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2007 | 79 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2007 | 212 | 0.020 |
Why?
|
| Massachusetts | 1 | 2019 | 8663 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2015 | 2488 | 0.020 |
Why?
|
| Middle Aged | 6 | 2017 | 213383 | 0.020 |
Why?
|
| Neoplasms | 1 | 2015 | 21683 | 0.020 |
Why?
|
| Consensus | 1 | 2015 | 2959 | 0.020 |
Why?
|
| Urine | 1 | 2007 | 370 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 1504 | 0.020 |
Why?
|
| Sample Size | 1 | 2008 | 845 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2017 | 3229 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2010 | 1534 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2759 | 0.010 |
Why?
|
| Decision Making | 1 | 2017 | 3887 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 3508 | 0.010 |
Why?
|
| Syndrome | 1 | 2009 | 3251 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 3843 | 0.010 |
Why?
|
| Alleles | 1 | 2014 | 6933 | 0.010 |
Why?
|
| Child, Preschool | 6 | 2012 | 41006 | 0.010 |
Why?
|
| Internet | 1 | 2014 | 3064 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2007 | 694 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8324 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2008 | 2373 | 0.010 |
Why?
|
| Time Factors | 2 | 2012 | 40075 | 0.010 |
Why?
|
| Follow-Up Studies | 3 | 2012 | 39050 | 0.010 |
Why?
|
| Amputation, Traumatic | 1 | 1980 | 123 | 0.010 |
Why?
|
| Veins | 1 | 1984 | 770 | 0.010 |
Why?
|
| Finger Injuries | 1 | 1980 | 139 | 0.010 |
Why?
|
| Genotype | 1 | 2014 | 12951 | 0.010 |
Why?
|
| Cryptorchidism | 1 | 1980 | 125 | 0.010 |
Why?
|
| Research Design | 1 | 2015 | 5987 | 0.010 |
Why?
|
| Femoral Vein | 1 | 1979 | 159 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2009 | 2684 | 0.010 |
Why?
|
| Toes | 1 | 1979 | 206 | 0.010 |
Why?
|
| Adolescent | 5 | 2017 | 85781 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2010 | 2151 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 11031 | 0.010 |
Why?
|
| Fingers | 1 | 1980 | 513 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 6171 | 0.010 |
Why?
|
| Testis | 1 | 1980 | 803 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 40561 | 0.010 |
Why?
|
| Survival Rate | 1 | 2009 | 12788 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1979 | 845 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 15519 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 1979 | 1074 | 0.010 |
Why?
|
| Graft Survival | 1 | 1984 | 3737 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 21827 | 0.010 |
Why?
|
| Rabbits | 1 | 1979 | 4894 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2012 | 5788 | 0.010 |
Why?
|
| Infant | 3 | 2010 | 35136 | 0.010 |
Why?
|
| Micrognathism | 1 | 1970 | 57 | 0.010 |
Why?
|
| Aged | 4 | 2012 | 163280 | 0.010 |
Why?
|
| Genitalia | 1 | 1970 | 112 | 0.010 |
Why?
|
| Algorithms | 1 | 2009 | 13881 | 0.010 |
Why?
|
| Child | 4 | 2010 | 77709 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 35421 | 0.000 |
Why?
|
| Transplantation, Autologous | 2 | 1980 | 2124 | 0.000 |
Why?
|
| Mice | 1 | 2011 | 81183 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2010 | 63114 | 0.000 |
Why?
|
| Blood Circulation | 1 | 1984 | 251 | 0.000 |
Why?
|
| Pedigree | 1 | 1970 | 4644 | 0.000 |
Why?
|
| Scrotum | 1 | 1980 | 115 | 0.000 |
Why?
|
| Methods | 1 | 1979 | 1129 | 0.000 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1980 | 744 | 0.000 |
Why?
|
| Luteinizing Hormone | 1 | 1980 | 869 | 0.000 |
Why?
|
| Age Factors | 2 | 1984 | 18370 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1984 | 6365 | 0.000 |
Why?
|
| Testicular Neoplasms | 1 | 1980 | 804 | 0.000 |
Why?
|
| Phenotype | 1 | 1970 | 16365 | 0.000 |
Why?
|
| Thrombosis | 1 | 1984 | 2968 | 0.000 |
Why?
|
| Prognosis | 1 | 1984 | 29063 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1984 | 53288 | 0.000 |
Why?
|